Egg Freezing Gains Popularity in India: Dr. S. Vyjayanthi on the Future of Fertility Preservation

Hyderabad (Telangana) [India], September 25:  Fertility preservation is no longer a subject confined to medical textbooks and oncology wards—it is now part of mainstream conversations among India’s urban, career-driven women. One procedure leading this change is egg freezing, and guiding this shift with expertise and compassion is Dr S. Vyjayanthi, Director of MotherToBe Fertility Centre and […]

Read More

Perzea Launch Strengthens Hetero Healthcare’s Oncology Leadership Through Partnership with Enzene Biosciences

Hetero Healthcare and Enzene launched Perzea, India’s most affordable Pertuzumab biosimilar Hyderabad (Telangana) [India], September 25: Hetero Healthcare Limited, in strategic collaboration with Enzene Biosciences, has launched Perzea, India’s most affordable Pertuzumab biosimilar. The introduction of this targeted therapy for HER2-positive breast cancer demonstrates the synergy between two healthcare leaders committed to advanced cancer treatment accessibility. Innovation Meets […]

Read More

Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India

Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with Enzene Biosciences Limited, this breakthrough aims to reduce the economic barriers faced by thousands of HER2-positive breast cancer patients. […]

Read More

Perzea Launch by Hetero Healthcare and Enzene Supports India’s Vision of Accessible Cancer Care

Hyderabad (Telangana) [India], September 25: Reinforcing the Government of India’s mission to provide equitable healthcare, Hetero Healthcare Limited, in partnership with Enzene Biosciences, has launched Perzea, its most affordable biosimilar Pertuzumab for HER2-positive breast cancer. This initiative underlines the critical need for advanced cancer treatment accessibility in the country. Closing the Treatment Gap Pertuzumab, a globally accepted monoclonal antibody therapy, […]

Read More

Best Shilajit for Men in India: ACTIZEET Shilajit Leads the Market

Kolkata (West Bengal) [India], September 24: In an era where men are increasingly looking for safe, natural, and effective solutions to boost energy, strength, and overall vitality, ACTIZEET has emerged as the undisputed leader in the Shilajit market. With a legacy of purity, authenticity, and trust, ACTIZEET proudly positions itself as the best Shilajit for men in India, setting the […]

Read More